Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost.
- 1 June 1998
- journal article
- case report
- Published by Springer Nature in Intensive Care Medicine
- Vol. 24 (6) , 631-634
- https://doi.org/10.1007/s001340050628
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Caution with use of inhaled nitric oxideThe Lancet, 1996
- Aerosolized Prostacyclin and Iloprost in Severe Pulmonary HypertensionAnnals of Internal Medicine, 1996
- Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1996
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Rebound pulmonary hypertension on withdrawal from inhaled nitric oxideThe Lancet, 1995
- Effects of aerosolized prostacyclin in severe pneumonia. Impact of fibrosis.American Journal of Respiratory and Critical Care Medicine, 1995
- Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous ProstacyclinAnnals of Internal Medicine, 1994
- Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension.Heart, 1993
- Aerosolised prostacyclin in adult respiratory distress syndromeThe Lancet, 1993
- Survival in Patients with Primary Pulmonary HypertensionAnnals of Internal Medicine, 1991